Related references
Note: Only part of the references are listed.When and how do patients with cardiac amyloidosis die?
F. Escher et al.
CLINICAL RESEARCH IN CARDIOLOGY (2020)
Mortality after hospital admission for heart failure: improvement over time, equally strong in women as in men
J. Buddeke et al.
BMC PUBLIC HEALTH (2020)
Diagnostic delay in wild type transthyretin cardiac amyloidosis - A clinical challenge
Bertil Ladefoged et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2020)
Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: safety run-in results of ANDROMEDA
Giovanni Palladini et al.
BLOOD (2020)
Epidemiology of Atrial Fibrillation in the 21st Century Novel Methods and New Insights
Jelena Kornej et al.
CIRCULATION RESEARCH (2020)
A novel mass spectrometry method to identify the serum monoclonal light chain component in systemic light chain amyloidosis
Faye A. Sharpley et al.
BLOOD CANCER JOURNAL (2019)
Epidemiology of Cardiac Amyloidosis-Associated Heart Failure Hospitalizations Among Fee-for-Service Medicare Beneficiaries in the United States
Lauren G. Gilstrap et al.
CIRCULATION-HEART FAILURE (2019)
Cardiac Amyloidosis A Rare Disease in Older Adults Hospitalized for Heart Failure?
Jan M. Griffin et al.
CIRCULATION-HEART FAILURE (2019)
Transthyretin Amyloid Cardiomyopathy JACC State-of-the-Art Review
Frederick L. Ruberg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Association of Carpal Tunnel Syndrome With Amyloidosis, Heart Failure, and Adverse Cardiovascular Outcomes
Emil L. Fosbol et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Digoxin Use in Cardiac Amyloidosis
Joseph P. Donnelly et al.
JOURNAL OF CARDIAC FAILURE (2019)
Digoxin use in systemic light-chain (AL) amyloidosis: contra-indicated or cautious use?
Eli Muchtar et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)
Cardiac amyloidosis
Ana Martinez-Naharro et al.
CLINICAL MEDICINE (2018)
Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment
Omar K. Siddiqi et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2018)
Seven factors predict a delayed diagnosis of cardiac amyloidosis
Eve Bishop et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2018)
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
Mathew S. Maurer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis
Ali M. Agha et al.
OPEN HEART (2018)
Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
Adam Castano et al.
EUROPEAN HEART JOURNAL (2017)
Clinical characteristics of wild-type transthyretin cardiac amyloidosis: disprovingmyths
Esther Gonzalez-Lopez et al.
EUROPEAN HEART JOURNAL (2017)
Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response
Martha Grogan et al.
HEART (2017)
Occult Transthyretin Cardiac Amyloid in Severe Calcific Aortic Stenosis Prevalence and Prognosis in Patients Undergoing Surgical Aortic Valve Replacement
Thomas A. Treibel et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2016)
Natural History of Wild-Type Transthyretin Cardiac Amyloidosis and Risk Stratification Using a Novel Staging System
Martha Grogan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study
Kasper Adelborg et al.
BMJ OPEN (2016)
Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study
Jens Sundboll et al.
BMJ OPEN (2016)
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
Esther Gonzalez-Lopez et al.
EUROPEAN HEART JOURNAL (2015)
Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
Morie A. Gertz et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
The Danish National Patient Registry: a review of content, data quality, and research potential
Morten Schmidt et al.
CLINICAL EPIDEMIOLOGY (2015)
Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
Niels Weinhold et al.
BLOOD (2014)
Nuclear imaging modalities for cardiac amyloidosis
Sabahat Bokhari et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2014)
Epidemiology of atrial fibrillation: European perspective
Massimo Zoni-Berisso et al.
CLINICAL EPIDEMIOLOGY (2014)
Improved Survival After Heart Failure: A Community-Based Perspective
Samuel W. Joffe et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Cardiac Amyloidosis
C. Cristina Quarta et al.
CIRCULATION (2012)
The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
C. Berry et al.
EUROPEAN HEART JOURNAL (2012)
The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients
Sandra K. Thygesen et al.
BMC MEDICAL RESEARCH METHODOLOGY (2011)
Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis
Lawreen H. Connors et al.
AMERICAN HEART JOURNAL (2009)
Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: A population-based autopsy study
Maarit Tanskanen et al.
ANNALS OF MEDICINE (2008)
Intracardiac thrombosis and embolism in patients with cardiac amyloidosis
DaLi Feng et al.
CIRCULATION (2007)
Evidence of improving prognosis in heart failure - Trends in case fatality in 66 547 patients hospitalized between 1986 and 1995
K MacIntyre et al.
CIRCULATION (2000)
Share Paper
